CITADEL ADVISORS LLC

Position in YARW — Yarrow Bioscience, Inc.

CIK 1423053 MIAMI, FL

Position in YARW

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$307,636

+$289,931 QoQ

Shares Held

514,443

+1585.3% QoQ

Ownership

1.54%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names. YARW ranks #285 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	2,182,571	$356,894,009
2	ONC	BeOne Medicines Ltd.	1,032,298	$306,561,536
3	BMRN	Biomarin Pharmaceutical Inc	4,512,634	$254,918,694
4	JAZZ	Jazz Pharmaceuticals plc	1,259,444	$238,097,887
5	MDGL	Madrigal Pharmaceuticals, Inc.	453,843	$237,573,195
6	BBIO	BridgeBio Pharma, Inc.	3,173,940	$235,696,783
7	TERN	Terns Pharmaceuticals, Inc.	3,218,810	$169,695,662
8	PTGX	Protagonist Therapeutics, Inc	1,551,900	$163,570,260

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$307,636	514,443	+1585.3%	Shares	Defined	2026-05-15
2025-12-31	$17,705	30,526	-97.1%	Shares	Defined	2026-02-17
2025-06-30	$1,716,115	1,040,070	-5.5%	Shares	Defined	2025-08-14
2025-03-31	$1,738,519	1,100,329	-10.6%	Shares	Defined	2025-05-15
2024-12-31	$4,122,030	1,230,457	+3.6%	Shares	Defined	2025-02-14
2024-09-30	$2,232,336	1,187,413	-2.0%	Shares	Defined	2024-11-14
2024-06-30	$2,385,799	1,211,066	+2.5%	Shares	Defined	2024-08-14
2024-03-31	$3,625,940	1,181,088	0.0%	Shares	Defined	2024-05-15
2023-12-31	$2,751,935	1,181,088	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.